Dimensional Fund Advisors LP reduced its stake in shares of Aptevo Therapeutics Inc (NASDAQ:APVO) by 15.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 893,338 shares of the biotechnology company’s stock after selling 163,391 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Aptevo Therapeutics were worth $2,046,000 as of its most recent SEC filing.

Separately, ValuEngine raised Aptevo Therapeutics from a “hold” rating to a “buy” rating in a research note on Thursday, October 12th.

In other Aptevo Therapeutics news, VP Randy Joe Maddux bought 25,000 shares of the business’s stock in a transaction dated Wednesday, November 15th. The shares were purchased at an average price of $2.76 per share, with a total value of $69,000.00. Following the completion of the purchase, the vice president now owns 25,000 shares in the company, valued at approximately $69,000. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 15.60% of the company’s stock.

Aptevo Therapeutics Inc (NASDAQ:APVO) opened at $3.01 on Friday. Aptevo Therapeutics Inc has a 52 week low of $1.15 and a 52 week high of $4.85. The company has a debt-to-equity ratio of 0.19, a quick ratio of 7.67 and a current ratio of 7.76.

Aptevo Therapeutics (NASDAQ:APVO) last released its earnings results on Thursday, November 9th. The biotechnology company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $2.25 by ($2.11). Aptevo Therapeutics had a net margin of 5.40% and a negative return on equity of 28.03%. equities analysts predict that Aptevo Therapeutics Inc will post 0.43 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Dimensional Fund Advisors LP Has $2.05 Million Holdings in Aptevo Therapeutics Inc (APVO)” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2018/02/09/dimensional-fund-advisors-lp-has-2-05-million-holdings-in-aptevo-therapeutics-inc-apvo.html.

About Aptevo Therapeutics

Aptevo Therapeutics Inc is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company’s technology is the ADAPTIR (modular protein technology) platform.

Want to see what other hedge funds are holding APVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aptevo Therapeutics Inc (NASDAQ:APVO).

Institutional Ownership by Quarter for Aptevo Therapeutics (NASDAQ:APVO)

Receive News & Ratings for Aptevo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptevo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.